
Nearly one in two of us will be diagnosed with cancer at some point in our lives. David Nicholas Wilkinson is one of them, twice over. In 2020, a colonoscopy found his bowel to be extremely healthy for a man his age. In 2023, a FIT test came back clear and, like almost everyone who takes one, he assumed that meant the all-clear. In 2024, a second colonoscopy found bowel cancer. Stage 4. He was told his tumour was 5-6 years old. What went wrong? A FIT test looks for blood. Wilkinson’s tumour never bled. Nor do a great many others. 1 IN 2 follows Wilkinson through his own treatment, where he discovers a steep rise in bowel cancer among people far too young to be screened for it, and far too young, it seems, to be believed. Among those who tell him their stories is a bowel surgeon whose own symptoms were dismissed by her oncologist colleagues and in part by herself because she was only 44.
What critics are saying
Verdicts use the same scale as your list: highly recommended through avoid — plus optional scores and blurbs.
Nobody on Critic, Sir! has logged a verdict for this title yet. The silence is either respectful or suspicious.
Sign in and use Add to My List below to share your own verdict.
Cast
Watching Lists
to create and edit public lists.
Loading lists…
Purchase & Discovery
Find this title on Amazon
Digital
Prime Video & digitalAmazon mixes rent, buy, and Prime in one place — one search covers the usual options.
Physical edition
4K Blu-ray & physical releasesSearch on AmazonOfficial merchandise
Official-style merch searchApparel, collectibles, and moreAs an Amazon Associate, Critic, Sir! earns from qualifying purchases. Full disclosure


